News
07-21-2009, 09:12 AM
Rhode Island Hospital is one of only four sites across the country to participate in a new clinical trial called the DIGNITY Study. The study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction with mild hyperthermia (a form of heat therapy) for treating recurrent chest wall breast cancer.
More... (http://www.medicalnewstoday.com/articles/158256.php)
More... (http://www.medicalnewstoday.com/articles/158256.php)